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Abstract. Quinoline-2,4-diones reacted with 2-(2-oxo-1,2-dihydroindol-3-
ylidene)malononitrile in pyridine to give 2'-amino-2,5'-dioxo-5',6'-dihydro-
spiro(indoline-3,4'-pyrano[3,2-c]quinoline)-3'-carbonitriles in good  to excellent 
yields. The structures of all new products were proven using one- and two-
dimensional NMR, IR, and mass spectral data, and in four cases X-ray structural 
analyses. The possible mechanism for the reaction is also discussed. 
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 2 
Introduction 1 
Great efforts have been made to synthesis, characterize and investigate the 2 
biological activities of these compounds. They possess very promising 3 
biological activities as anticonvulsant [1-3], antibacterial [4], anti-4 
Alzheimer [5], antimicrobial [6], anti-dermatities [7], anticancer [8], and 5 
pain-relief [9], in addition to their medical, agricultural and industrial uses 6 
[10-12]. In general, spiro-compounds have also drawn tremendous interest 7 
of researchers in synthetic organic chemistry and medicinal chemistry due 8 
to their extensive applications in biology and pharmacology [13]. Indeed, 9 
quinolones represent a class of fused ring systems with interesting essential 10 
role in the construction of many bioactive compounds, that they can exhibit 11 
antibacterial [14], antifungal [14], anti-tumor [15], anticancer [16], 12 
antituberculosis [16], antibiotic [17], anti-microbial [18], anti-inflammatory 13 
activities [18].  However, they have herbicides [19], and insecticides agent 14 
[20]. On the other hand, isatinemalononitrile is a scaffold for the synthesis 15 
of fused spiro-compounds [21], many of its derivatives are potent inhibiting 16 
caspase [22]. The heterocyclic spiro-oxindole framework is an important 17 
structural motif in natural products which can act as potent non-peptide 18 
inhibitors [23]. These compounds are very interesting: they can act as 19 
antibacterial and anti-HIV agents [24],  and exhibit biological activities 20 
[25], such as antitumor and anticancer [26] and cellularevaluation [27]. 21 
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 3 
To extend the knowledge around the new spiro-compounds, we focused our 1 
searches to synthesis a new class of spiro-compounds which we expect they 2 
will have importance activities in medicinal and industrial area. Previously, 3 
Aly et al., synthesized fused spiro-pyranoindanoparacyclophanes [28], 4 
spiro-pyridazinocyclohexadiene as well as spiro-5 
thiadiazolopyrimidinocyclo-hexadiene derivatives [29], and spiro(indole-6 
3,3′-[1,2,4]-triazol)-2(1H)-ones [30]. 7 
For all these reasons, synthesis of spiro-indolinepyrano[3,2-c]quinolines 8 
continues to attract interest. Herein we describe the synthesis of a class of 9 
new spiro-compounds, via the reaction of quinoline-2,4-(1H,3H)-diones   10 
1a-f with 2-(2-oxo-1,2-dihydroindol-3-ylidene)malononitrile (2). 11 
2. Results and Discussion 12 
Refluxing equimolar amounts of 1,6-disubstituted quinoline-2,4-(1H,3H)-diones 13 
1a-f with 2-(2-oxo-1,2-dihydroindol-3-ylidene)-malononitrile (2) in dry pyridine 14 
solution led to the formation of spiro(indoline-3,4'-pyrano[3,2-c]quinoline)-3'-15 
carbonitriles 3a-f in 85-92% yields (Scheme 1).  16 
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 1 
Scheme 1. Synthesis of spiro-compounds 3a-f via reaction between quinoline-2 
2,4-diones 1a-f and 2. 3 
To confirm the structures of all the obtained products, elemental analyses, IR, 4 
NMR (1H, 13C, 2D NMR, 15N) and mass spectra were performed; these and 5 
elemental analyses were in good agreement with the assigned structures. To 6 
illustrate the structure elucidation, we choose a representative example, 2'-amino-7 
6’-methyl-2,5'-dioxo-5',6'-dihydrospiro(indoline-3,4'-pyrano[3,2-c]quinoline)-3'-8 
carbonitrile (3e) (Table 1). According to elemental analysis and mass 9 
spectrometry, compound 3e has the gross formula C21H14N4O3, resulting from 10 
combination of one molecule of N-methylquinoline-2,4-dione (1e) with one 11 
molecule of 2. Our first impression was that the reaction might give either 3e, 4, 12 
or 5 (Figure 1). The NMR data appear in Table 1. 13 
MCCM_Template_Vers 4   June 2017    
 5 
 1 
Figure 1. Alternative expected structure of compound 3e. 2 
Table 1. NMR assignment of compound 3e 1H NMR 3 
1H NMR                                         1H-1H COSY                            Assig. 
10.54 (bs; 1H)                                                                                 NH-1 
8.07 (d, J = 8.0; 1H)                           7.76                                      H-10' 
7.76 (“dt”, Jt = 7.3, Jd = 1.1; 1H)       8.07,7.59,7.45                      H-8' 
7.59 (d, J = 8.6; 1H)                           7.76,7.45                              H-7' 
7.48 (bs; 2H)                                                                                   NH2 
7.45 (t, J = 7.7; 1H)                            7.76                                     H-9' 
7.18 (t, J = 7.6; 1H)                            7.02,6.88,6.85                     H-6 
7.02 (d, J = 7.2; 1H)                           6.88,6.85                             H-4 
6.88 (t, J = 7.5; 1H)                            7.18,7.02                             H-5 
6.85 (d, J = 7.8; 1H)                           7.18,7.02                             H-7 
3.49 (s; 3H)                                                                                    CH3 
15N NMR                  HSQC                       HMBC                           Assig. 
140.5                                                       7.59,3.49                        N-6' 
136.3                         10.54                     6.85                                N-1 
75.2                           7.48                                                              NH2 
13C NMR                 HSQC              HMBC                                     Assig. 
177.81                                              10.54                                      C-2 
158.87,158.72                                  7.48,3.49                                C-5',2' 
151.46                                              8.07,7.59                                C-10'a     
142.48                                              10.54,7.18,7.02,6.85              C-7a 
138.64                                              8.07,7.76,3.49                        C-6'a 
134.25                                              10.54,6.88,6.85                      C-3a 
132.23                   7.76                    8.07,7.59                                C-8' 
128.28                   7.18                    7.02,6.88                                C-6 
123.40                   7.02                    7.18                                        C-4 
122.41,122.36       8.07,7.45            7.76,7.59                               C-9',10' 
121.66                   6.88                    6.85                                        C-5 
117.43                                                                                             CN 
115.03                   7.59                    3.49                                        C-7' 
112.27                                              7.59,7.48                                C-10'b 
109.18                   6.85                    6.88                                        C-7 
106.48                                                                                             C-4'a 
57.22                                                7.48                                        C-3' 
48.15                                                10.54,7.02,6.88,6.85              C-3,4' 
29.19                      3.94                                                                  CH3 
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The 1H spectrum consists of two four-spin coupled networks in the aromatic 1 
region, two broadened singlets (1H and 2H), and a methyl singlet. The 13C 2 
spectrum has 21 lines, consistent with 3e but excluding structure 4; eighteen are in 3 
the normal sp2region between C = 100-160 ppm. Three nitrogen atoms were 4 
observed, all but the nitrile. One of the aromatic proton systems appears between 5 
H = 8.07-7.45 ppm and the other between H = 7.18-6.85 ppm. To differentiate 6 
the two aromatic systems, the nearby nitrogen atoms are convenient starting 7 
points. The sp2 nitrogen at N = 136.3 ppm, gives HSQC correlation with the 1H 8 
broadened singlet at H = 10.54 ppm; these two signals are assigned as N-1 and the 9 
attached proton. Two carbons at C = 142.48 and 134.25 ppm give HMBC 10 
correlation both with H-1 and with protons in the system H = 7.18-6.85 ppm, and 11 
are assigned as C-7a and C-3a in some order. H-1 also gives HMBC correlation 12 
with the carbonyl carbon at C = 177.81 ppm, which is assigned as C-2, and the 13 
sp3 carbon at C = 48.15 ppm, assigned as the spiro carbon C-3,4'. The spiro 14 
carbon gives HMBC correlation with the proton doublet at H = 7.02 ppm, 15 
assigned as H-4 (three bonds away from the spiro carbon); the attached carbon 16 
appears at C = 123.40 ppm. H-4 also gives HMBC correlation with the 17 
aforementioned carbon at C = 142.48 ppm, which is assigned as C-7a (three 18 
bonds away from H-4); by subtraction, the carbon at C = 134.25 ppm, is assigned 19 
as C-3a. Also, C-7a gives HMBC correlation with a proton triplet at H = 7.18 20 
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 7 
ppm, assigned as H-6; this is another three-bond correlation, and the attached 1 
carbon appears at C = 128.28 ppm. The remaining triplet and doublet in this 2 
aromatic proton system appear at H = 6.88 and 6.85 ppm, and are assigned as H-5 3 
and H-7 respectively; the attached carbons appear at C = 121.66 and 109.18.  The 4 
other sp2 nitrogen, at N = 140.5, gives HMBC correlation with an aromatic 5 
doublet at H = 7.59 ppm, and a methyl singlet at H = 3.49 ppm. This nitrogen is 6 
assigned as N-6' and the methyl singlet as H-6'b; the carbon attached to H-6'b 7 
appears at C = 29.19 ppm, and is assigned as C-6'b. The proton at H = 7.59 is 8 
assigned as H-7', which is three bonds from N-1; its attached carbon appears at C 9 
= 115.03 ppm, and gives HMBC correlation with H-6'b. On the other hand, H-6'b 10 
also gives HMBC correlation with a carbon at C = 138.64, assigned as C-6'a; this 11 
is a three-bond correlation. C-6'a also gives HMBC correlation with an aromatic 12 
doublet at H = 8.07 and a triplet at H = 7.76 ppm, assigned as H-10' and H-8' 13 
respectively; the attached carbons appear at C = 122.41 or 122.36, and at C = 14 
132.23 ppm. The remaining triplet in this ring appears at H = 7.45 ppm, and is 15 
assigned as H-9'; its attached carbon is the other of C = 122.41 and 122.36. A 16 
carbon at C = 151.46 ppm gives HMBC correlation with H-10' and H-8', and is 17 
assigned as C-10'a. The remaining carbons at C = 158.87, 158.72, 117.43, 112.27, 18 
106.48, and 57.22 ppm, must be C-2', 3', CN, 4'a, 5', and 10'b. The two carbons at 19 
C = 158.87 and 158.72 ppm, give HMBC correlation with H-6'b and the 20 
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broadened 2H signal at H = 7.48 ppm; these carbons are assigned as C-2' (which 1 
should correlate with the NH2 group) and C-2' (which is three bonds from H-2 
6'b).The broadened protons just mentioned give HSQC correlation with the sp3 3 
nitrogen at N = 75.2, assigned as NH2. The upfield carbon at N = 57.22 gives 4 
HMBC correlation with NH2, and is assigned as C-3'; its upfield shift is attributed 5 
to the observed trends in δ values for C-atoms in push-pull alkenes [31,32]. The 6 
carbon at C = 112.27 gives HMBC correlation with H-7' and NH2; it is assigned 7 
as C-10'b, which is four bonds from each of these protons. The remaining carbons 8 
appear at C = 117.43 and 106.48 ppm, and must be CN and C-4'a; based on 9 
chemical shifts, the downfield of the two is assigned as the nitrile carbon-CN and 10 
the upfield carbon as C-4'a. 11 
As another example, we choose 3a. In its IR spectrum, bands at 3207-3372 cm-1 12 
can be assigned to NH2 and NH groups, and strong absorption at 2205 cm
-1 is 13 
characteristic of a cyano group. Several peaks appear at 1725-1642 and 1600, 1596 14 
cm-1 as a result of C=O stretching and skeletal vibration of the aryl group, 15 
respectively. The structure of compound 3a was previously prepared [21f], 16 
however its detailed NMR data were not extensively reported. The NMR spectra of 17 
3a (Table 2) are very similar to those of 3e, except that instead of the N-methyl 18 
group, there is a broadened 1H singlet at H = 11.75 ppm, assigned as NH-6. This 19 
proton gives HSQC correlation with N-6, and gives HMBC correlation with C-2', 20 
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C-3'. C-3,4', C-5', C-9', C-10', and C-10'b.  All these correlations are over four 1 
bonds or fewer; the structure assignment of 3a is unambiguously confirmed by an 2 
X-ray crystal structure (Figure 2). 3 
Table 2. NMR assignments of compound 3a 1H NMR 4 
1H NMR                                           1H-1H COSY                     Assig. 
11.75 (bs; 1H)                                                                           NH-6'            
10.53 (bs; 1H)                                                                           NH-1 
7.96 (d, J = 7.8; 1H)                           7.63                                H-10' 
7.63 (ddd, J = 8.3, 7.2, 1.1; 1H)         7.96, 7.36                       H-8' 
7.46 (bs; 2H)                                                                             NH2 
7.36 (d, J = 8.1; 1H)                           7.63                                H-7' 
7.34 (dd, J = 7.5, 7.5; 1H)                  7.63                                H-9' 
7.19 (ddd, J = 7.6, 7.6, 0.7; 1H)         7.04, 6.90, 6.84              H-6 
7.04 (d, J = 7.3; 1H)                           7.19, 6.90, 6.84              H-4 
6.90 (dd, J = 7.5, 7.4; 1H)                  7.19, 7.04, 6.84              H-5 
6.84 (d, J = 7.7; 1H)                           7.19, 7.04, 6.90              H-7 
15N NMR                  HSQC                       HMBC                   Assig. 
146.2                         11.75                        7.36                        N-6' 
136.3                         10.54                        6.84                        N-1 
75.3                           7.46                                                         NH2 
13C NMR                 HSQC          HMBC                             Assig. 
177.83                                         10.54                                       C-2 
159.40,158.94                             11.75,7.48                               C-5',2' 
152.39                                         11.75,7.96,7.48,7.36               C-10'a     
142.37                                         10.54,7.19,7.04,6.90,6.84       C-7a 
137.82                                         11.75,7.96,7.63,7.34               C-6'a 
134.31                                         10.54,7.19,6.90,6.84               C-3a 
131.77                   7.63               7.96                                         C-8' 
128.28                   7.19               7.04,6.90                                 C-6 
123.46                   7.04               7.19                                         C-4 
122.16                   7.34               7.63,7.36                                 C-9' 
121.91                   6.90               6.84                                         C-5 
121.68                   7.96               7.63                                         C-10' 
117.48                                                                                         CN 
115.37                   7.36               11.75,7.34                               C-7' 
111.55                                         11.75,7.63,7.36,7.34               C-10'b 
109.22                  6.84                7.18,7.04,6.90                         C-7 
106.99                                         11.75                                       C-4'a 
57.18                                           7.48                                         C-3' 
47.75                                           11.75,10.54,7.04,6.84             C-3,4 '                                                               
 5 
The spectra of the N-ethyl compound 3f are essentially identical to those of 3e; 6 
because spiro carbon C-14 is a stereogenic center, protons H-101 are diastereotopic 7 
[33], and the N-ethyl group appears as an ABX3 system (3f). The structure 8 
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assignment of 3f is unambiguously confirmed by an X-ray crystal structure; the 1 
crystal contains one equivalent of DMF, the recrystallization solvent (Fig. 5). 2 
 3 
Figure 2. Molecular structure of 3a.DMF 2'-Amino-2,5'-dioxo-5',6'-dihydrospiro(indoline-3,4'-pyrano-[3,2-4 
c]quinoline)-3'-carbonitrile.DMF (1:1). Displacement parameters are drawn at 50% probability level. 5 
 6 
Figure 3. Molecular structure of 3b.2DMF. (2'-amino-9'-chloro-2,5'-dioxo-5',6'-dihydrospiro[indoline-3,4'-7 
pyrano[3,2-c]quino-line)-3'-carbonitrile.2DMF. Displacement parameters are drawn at 50% probability level. 8 
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 1 
Figure 4. Molecular structure of 3c.2DMF. 2'-amino-9'-bromo-2,5'-dioxo-5',6'-dihydrospiro(indoline-3,4'-2 
pyrano[3,2-c]quino-line)-3'-carbonitrile.2DMF (1:2). Displacement parameters are drawn at 50% probability 3 
level. 4 
 5 
 6 
Figure 4. Molecular structure of 3d DMF. Displacement parameters are drawn at 50% probability level 7 
 8 
 9 
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 1 
Figure 5. Molecular structure of 3f.DMF 2'-Amino-6'-ethyl-2,5'-dioxo-5',6'-dihydrospiro(indoline-3,4'-2 
pyrano[3,2-c]quinoline)-3'-carbonitrile.DMF (1:1). Displacement parameters are drawn at 50% probability 3 
level. 4 
From the 2D NMR correlations the structures 5 can be excluded, but another 5 
confirmation was made by using X-ray analysis as shown in Figures 2-5.  6 
We propose the mechanism shown in Scheme 2. Conjugate addition of 1 to 2, 7 
catalyzed by base, would give intermediate B. Cyclization of B would then occur 8 
to give intermediate C and, after proton transfer, finally give products 3a-f 9 
(Scheme 2). 10 
 11 
Scheme 2. Suggested mechanism for formation of products 3a-f 12 
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Most indicative is the ring conformation in crystals of compounds 3a-c and 3f are 1 
distorted under the effect of intermolecular interactions, as is evidenced by short 2 
intermolecular contacts. The complexes are stabilized by intermolecular N-H⋯O 3 
and C-H⋯O hydrogen bonds between the hydrogen atoms situated inside the 4 
cavity of the macrocycle, the oxygen and nitrogen atoms of the 5 
dimethylformamide and water molecules. 6 
3. Conclusion 7 
Reaction of 2,4-quinolinediones with isatinemalononitrile yields spiro compounds 8 
in good yields; structures were established by solution-phase spectroscopy and X-9 
ray crystallographic analysis.    10 
4. Experimental 11 
4.1. General 12 
NMR spectra were measured in DMSO-d6 on a Bruker AV-400 spectrometer 13 
(Bruker BioSpin Corp., Billerica, MA, USA) (400.13 MHz for 1H, 100.13 MHz for 14 
13C, and 40.55 MHz for 15N) at Florida Institute of Technology, USA. The 1H and 15 
13C chemical shifts are given relative to internal standard TMS; 15N shifts are 16 
reported versus external liquid ammonia. For preparative thin layer chromatography 17 
(PLC), glass plates (20 x 48 cm) were covered with a slurry of silica gel Merck 18 
PF254 and air dried and developed using the solvents listed. Zones were detected 19 
by quenching of indicator fluorescence upon exposure to 254 nm UV light. 20 
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Elemental analyses were carried in the National Research Center, Dokki, Cairo, 1 
Egypt. Mass spectrometry was performed by electron impact at 70 eV, with a 2 
Finnigan Mat 8430 spectrometer in the National Research center, Dokki, Cairo, 3 
Egypt. IR spectra using KBr pellets, were run on a FT-IR (Bruker), Minia 4 
University, El-Minia, Egypt.  5 
4.2. Starting materials 6 
Quinoline-2,4-diones 1a-f were prepared according to the literature [34].  7 
4.3. X-ray crystal structure determination 8 
The single-crystal X-ray diffraction study was carried out on a Bruker D8 Venture 9 
diffractometer with Photon100 detector at 123(2) K using Cu-Kα radiation (3a, 3b, 10 
3f, λ = 1.54178 Å) or Mo-Kα radiation (3c, λ = 0.71073 Å). Direct Methods 11 
(SHELXS-97) [35] were used for structure solution and refinement was carried out 12 
using SHELXL-2014 (full-matrix least-squares on F2) [36]. Hydrogen atoms were 13 
localized by difference electron density determination and refined using a riding 14 
model (H(N) and H(O) free. Semi-empirical absorption corrections were applied. 15 
For 3a and 3c an extinction correction was applied.  16 
3a: colourless crystals, C20H12N4O3∙ 2(C3H7NO), Mr = 502.53, crystal size 0.16 × 17 
0.10 × 0.08 mm, monoclinic, space group P21/c (No. 14), a = 10.8078(3) Å, b = 18 
21.4185(6) Å, c = 11.0025(3) Å, β = 106.635(1)°, V = 2440.34(12) Å3, Z = 4, ρ = 19 
1.368 Mg/m-3, µ(Cu-Kα) = 0.805 mm
-1, F(000) = 1056, 2max = 144.4°, 26760 20 
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reflections, of which 4805 were independent (Rint = 0.042), 351 parameters, 4 1 
restraints, R1 = 0.038 (for 4182 I > 2σ(I)), wR2 = 0.097 (all data), S = 1.06, largest 2 
diff. peak / hole = 0.297 / -0.206 e Å-3. 3 
3b: colourless crystals, C20H11ClN4O3 ∙ 2(C3H7NO), Mr = 536.97, crystal size 0.20 × 4 
0.16 × 0.10 mm, monoclinic, space group P21/c (No. 14), a = 11.0744(4) Å, b = 5 
21.3368(8) Å, c = 11.1215(4) Å, β = 107.884(1)°, V = 2500.94(16) Å3, Z = 4, ρ = 6 
1.426 Mg/m-3, µ(Cu-Kα) = 1.784 mm
-1, F(000) = 1120, 2max = 144.2°, 21016 7 
reflections, of which 4915 were independent (Rint = 0.027), 359 parameters, 4 8 
restraints, R1 = 0.036 (for 4445 I > 2σ(I)), wR2 = 0.097 (all data), S = 1.03, largest 9 
diff. peak / hole = 0.320 / -0.290 e Å-3. 10 
3c: colourless crystals, C20H11BrN4O3 ∙ 2(C3H7NO), Mr = 581.43, crystal size 0.25 × 11 
0.20 × 0.15 mm, monoclinic, space group P21/c (No. 14), a = 11.0650(5) Å, b = 12 
21.4404(11) Å, c = 11.2361(5) Å, β = 108.179(2)°, V = 2532.6(2) Å3, Z = 4, ρ = 13 
1.525 Mg/m-3, µ(Mo-Kα) = 1.673 mm
-1, F(000) = 1192, 2max = 55.2°, 39390 14 
reflections, of which 5834 were independent (Rint = 0.024), 360 parameters, 4 15 
restraints, R1 = 0.026 (for 5290 I > 2σ(I)), wR2 = 0.064 (all data), S = 1.05, largest 16 
diff. peak / hole = 0.483 / -0.572 e Å-3. 17 
3f: colourless crystals, C22H16N4O3 ∙ C3H7NO ∙ H2O, Mr = 475.50, crystal size 0.16 18 
× 0.10 × 0.04 mm, triclinic, space group P-1 (No. 2), a = 9.6532(5) Å, b = 19 
11.3165(6) Å, c = 12.6497(6) Å, α = 110.480(3)°, β = 102.514(3)°, γ = 107.481(3)°, 20 
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V = 1151.89(11) Å3, Z = 2, ρ = 1.371 Mg/m-3, µ(Cu-Kα) = 0.807 mm-1, F(000) = 1 
500, 2max = 136.4°, 11728 reflections, of which 4141 were independent (Rint = 2 
0.037), 333 parameters, 5 restraints, R1 = 0.055 (for 3170 I > 2σ(I)), wR2 = 0.155 3 
(all data), S = 1.05, largest diff. peak / hole = 0.354 / -0.254 e Å-3. 4 
CCDC-1519994 (3a), CCDC-1519995 (3b), CCDC-1519996 (3c sb897_hy ME-5 
86) and CCDC-1519997 (3f) contain the supplementary crystallographic data for 6 
this paper. These data can be obtained free of charge from The Cambridge 7 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.  8 
4.4. General Procedure 9 
4.5. Reaction of quinoline-2,4-diones 1a-f with 2 10 
A 100 mL round-bottom flask was flame-dried, a mixture of 1a-f (1 mmol), 2 (1 11 
mmol) and 20 ml dry pyridine was refluxed for 8-10 h with stirring (the reaction 12 
was followed by TLC analysis). After the reaction’s completion, solvent was then 13 
removed under vacuum and the residue was separated. The solid residue undergoes 14 
recrystallization from dry DMF to give pure crystals of spiro-compounds 3a-f. 15 
2'-Amino-2,5'-dioxo-5',6'-dihydrospiro(indoline-3,4'-pyrano-[3,2-16 
c]quinoline)-3'-carbonitrile (3a) .  Colorless crystals (303 mg, 85 %),  17 
M.p.: 298-300oC; IR (KBr, cm-1):  = 3372-3207 (NH, NH2), 3099 18 
(Ar-H), 2205 (CN),  1725, 1672, 1642 (C=O), 1600, 1596 (Ar-C=N, Ar-19 
C=C); NMR (DMSO-d6) (Table 1); MS (Fab, 70 eV, %): m/z  = 356 20 
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(M+,  100). Anal. Calcd. For  C20H12N4O3 : C, 67.41; H, 3.39; N, 15.72; 1 
Found: C, 67.55; H, 3.22; N, 15.66.  2 
2'-Amino-9'-chloro-2,5'-dioxo-5',6'-dihydro-spiro(indoline-3,4'-3 
pyrano[3,2-c]quinoline)-3'-carbonitrile(3b) .  Colorless crystals (360 4 
mg, 92%), M.p.: 320-2oC; IR (KBr, cm-1):  = 3350-3196 (NH, NH2),  5 
3031 (Ar-CH), 2928 (Ali-CH), 2193 (CN),  1716, 1669, 1654 (C=O),  6 
1605, 1593 (Ar-C=N, Ar-C=C); 1H NMR (400 MHz, DMSO-d6): δH = 7 
11.88 (bs, 1H; NH-6'),  10.55 (bs; 1H; NH-1), 8.00 (d, J = 2.3; 1H, H-8 
10'), 7.68 (dd, J = 8.8, 2.4; 1H, H-8'), 7.47 (bs; 2H, NH2),7.37 (d, J = 9 
8.8; 1H, H-7'), 7.19 (ddd, J  = 7.6, 7.6, 0.7; 1H, H-6), 7.05 (d, J = 7.3; 10 
1H, H-4), 6.90 (dd, J = 7.4, 7,4; 1H, H-5), 6.83 ppm (d, J = 7.7; 1H, H-11 
7) ppm; 13C NMR (100 MHz, DMSO-d6): δC = 177.58 (C-2), 159.18,  12 
158.77 (C-5',2'), 151.44 (C-10'a),  142.33 (C-7a), 136.55 (C-6'a),  13 
134.06 (C-3a), 131.71 (C-8'), 128.38 (C-6), 126.31 (C-9'), 123.56 (C-14 
4), 121.71 (C-5), 121.23 (C-10'), 117.48, 117.30 (CN,C-7'), 111.55 (C-15 
10'b), 109.24 (C-7), 107.98 (C-4'a),  57.09 (C-3'), 47.74 ppm (C-3,4') 16 
ppm; 15N NMR (DMSO-d6): δN = 146.0 (N-6'), 136.2 (N-1), 74.8 (NH2) 17 
ppm; MS (Fab, %): m/z  = 391 (M+1, 28), 390 (M+,  58). Anal. Calcd.  18 
for  C20H11ClN4O3 : C, 61.47; H, 2.84; Cl, 9.07; N, 14.34; Found: C,  19 
61.33; H, 3.01; Cl, 9.22; N, 14.29.  20 
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2'-Amino-9'-bromo-2,5'-dioxo-5',6'-dihydro-spiro(indoline-3,4'-1 
pyrano[3,2-c]quinoline)-3'-carbonitrile (3c) .  Colorless crystals (390 2 
mg, 90%), M.p.: > 360 oC; IR (KBr, cm-1):  = 3365-3195 (NH, NH2),  3 
3044 (Ar-CH), 2930 (Ali-CH), 2195 (CN),  1700, 1671, 1635 (C=O),  4 
1605, 1589 (Ar-C=N, Ar-C=C); 1H NMR (400 MHz, DMSO-d6): δH 5 
=11.87 (bs; 1H, NH-6'), 10.55 (bs; 1H, NH-1), 8.14 (d, J = 2.2; 1H, H-6 
10'), 7.79 (dd, J = 8.8, 2.2; 1H, H-8'), 7.48 (bs; 2H, NH2), 7.31 (d, J = 7 
8.8; 1H; H-7'), 7.18 (ddd, J = 7.6, 7.6, 0.9; 1H, H-6), 7.05 (d, J = 7.2; 8 
1H, H-4), 6.89 (dd, J = 7.5, 7.5; 1H, H-5), 6.83 ppm (d, J = 7.7; 1H, H-9 
7) ppm; 13C NMR (100 MHz, DMSO-d6): δC = 177.59 (C-2), 159.17,  10 
158.77 (C-5',2'), 151.36 (C-10'a),  142.33 (C-7a), 136.86 (C-6'a),  11 
134.36 (C-8'), 134.07 (C-3a), 128.38 (C-6), 124.22 (C-10'), 123.56 (C-12 
4), 121.71 (C-5), 117.62 (C-7'), 117.31 (CN), 114.01 (C-9'), 113.24 (C-13 
10'b), 109.24 (C-7), 107.98 (C-3a),  57.09 (C-3'), 47.74 ppm (C-3,4') 14 
ppm; 15N NMR (DMSO-d6): δN = 146.2 (N-6), 136.4 (N-4c), 75.1 (NH2) 15 
ppm; MS (Fab, %): m/z  = 435 (M+1, 28), 434 (M+,  56). Anal. Calcd.  16 
for  C20H11BrN4O3 : C, 55.19; H, 2.55; Br, 18.36; N, 12.87; Found: C,  17 
55.34; H, 2.62; Br, 18.19; N, 12.76.  18 
2'-Amino-9'-methyl-2,5'-dioxo-5',6'-dihydro-spiro(indoline-3,4'-19 
pyrano[3,2-c]quinoline)-3'-carbonitrile (3d) .  Colorless crystals (325 20 
mg, 88%), M.p. : 340-2oC  oC; IR (KBr, cm-1):  = 3370-3190 (NH, 21 
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NH2), 3033 (Ar-CH), 2922 (Ali-CH), 2198 (CN),  1705, 1670, 1638 1 
(C=O), 1610, 1587 (Ar-C=N, Ar-C=C); 1H NMR (400 MHz, DMSO-d6) : 2 
δH = 11.83 (bs; 1H, NH-6'), 10.69 (bs; 1H, NH-1), 7.94 (s; 1H, H-10'),  3 
7.62 (d, J = 8.4; 1H, H-8'), 7.61 (bs; 2H, NH2), 7.43 (d, J = 8.4; 1H, H-4 
7'), 7.35 (“t”, J = 7.6; 1H, H-6), 7.18 (d, J = 7.3; 1H, H-4), 7.06 (“t”, J 5 
= 7.4; 1H, H-5), 7.00 (d, J = 7.7, 1H, H-7), 2.59 ppm (s; 3H, CH3) 6 
ppm; 13C NMR (100 MHz, DMSO-d6): δC = 177.86 (C-2), 159.26,  7 
158.96 (C-5',2'), 152.23 (C-10'a),  142.37 (C-7a), 135.90 (C-6'a),  8 
134.39 (C-3a), 132.97 (C-8'), 131.27 (C-9'), 128.23 (C-6), 123.38 (C-9 
4), 121.64 (C-10'), 121.29 (C-5), 117.47 (CN), 115.30 (C-7'), 111.45 10 
(C-10'b), 109.19 (C-7), 106.94 (C-4'a), 57.19 (C-3'), 47.77 (C-3,4'),  11 
20.65 ppm (CH3) ppm. 
15N NMR (DMSO-d6): δN =145.5 (N-6'), 136.2 12 
(N-1), 74.8 (NH2) ppm; MS (Fab,  %): m/z  = 370 (M
+,  100). Anal.  13 
Calcd. for  C21H14N4O3 : C, 68.10; H, 3.81; N, 15.13; Found: C, 68.25; 14 
H, 3.99; N, 15.09.  15 
2'-Amino-6'-methyl-2,5'-dioxo-5',6'-dihydro-spiro(indoline-3,4'-16 
pyrano[3,2-c]quinoline)-3'-carbonitrile (3e) .  Colorless crystals (322 17 
mg, 87%), M.p. : 310-312 oC; IR (KBr, cm-1):  = 3359-3166 (NH, 18 
NH2), 2193 (CN), 1711, 1672, 1645 (C=O), 1626, 1598 (Ar-C=N, Ar-19 
C=C); NMR (DMSO-d6) (Table 2); MS (Fab, %): m/z  = 370 (M
+,  60).  20 
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Anal. Calcd. for  C21H14N4O3 : C, 68.10; H, 3.81; N, 15.13; Found: C,  1 
68.23; H, 3.78; N, 15.21.  2 
2'-Amino-6'-ethyl-2,5'-dioxo-5',6'-dihydro-spiro(indoline-3,4'-3 
pyrano[3,2-c]quinoline)-3'-carbonitrile (3f).  Colorless crystals (330 4 
mg, 86%), M.p. : 330-332 oC; IR (KBr, cm-1):  =3360-3192 (NH2 ,  5 
NH), 3106 (Ar-CH), 2967 (Ali-CH), 2205 (CN),  1725, 1672, 1642 6 
(C=O), 1600, 1578 (Ar-C=N, Ar-C=C); 1H NMR (400 MHz, DMSO-d6) : 7 
δH = 10.53 (bs; 1H, NH-1), 8.09 (dd, J = 8.0, 1.2; 1H, H-10'), 7.76 8 
(“dt”, J t = 7.2, Jd  = 1.3; 1H, H-8'), 7.64 (d, J = 8.6; 1H, H-7'), 7.48 (bs; 9 
2H, NH2), 7.43 (“t”, J = 7.6; 1H, H-9'), 7.18 (“dt”, J t  = 7.6, Jd  = 0.9, 10 
1H, H-6), 7.03 (d, J = 7.2; 1H, H-4 ), 6.88 (“t”, J = 7.5; 1H, H-5), 6.85 11 
(d, J = 7.8; 1H; H-7), 4.14 (ABX3,  JAB = 13.3, JAX = 7.0; 1H, CH2CH3),  12 
4.11 (ABX3,  JAB = 13.3, JBX = 7.0; 1H; CH2CH3), 1.08 ppm (ABX3,  JAX  13 
= JBX  = 7.0, 3H, CH2CH3) ppm; 
13C NMR (100 MHz, DMSO-d6): δC = 14 
177.84 (C-2), 158.88, 158.33 (C-5',2'), 151.49 (C-10'a), 142.46 (C-7a),  15 
137.58 (C-6'a), 134.27 (C-3a), 132.31 (C-8'), 128.29 (C-6), 123.37 (C-16 
4), 122.66 (C-10'), 122.27 (C-9'), 121.70 (C-5), 117.44 (CN), 114.73 17 
(C-7'), 112.49 (C-10'b), 109.21 (C-7), 106.42 (C-4'a), 57.22 (C-3'),  18 
48.13 (C-3,4'), 36.83 (N-CH2CH3), 12.62 ppm (N-CH2CH3); 
15N NMR 19 
(DMSO-d6): δN = 154.3 (N-6'), 136.5 (N-1), 75.1 ppm (NH2); MS (Fab,  20 
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%): m/z  = 384 (M+,  100). Anal. Calcd. for  C22H16N4O3 : C, 68.74; H, 1 
4.20; N, 14.58; Found: C, 68.88; H, 4.33; N, 14.41.  2 
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Figure Captions 10 
Scheme 1. Synthesis of spiro-compounds 3a-f via reaction between quinoline-2,4-diones 1a-f 11 
and 2. 12 
Figure 2. Molecular structure of 3a.DMF. 2'-Amino-2,5'-dioxo-5',6'-13 
dihydrospiro(indoline-3,4'-pyrano-[3,2-c]quinoline)-3'-carbonitrile.DMF (1:1). 14 
Displacement parameters are drawn at 50% probability level. 15 
Figure 3. Molecular structure of 3b. 2 DMF. (2'-amino-9'-chloro-2,5'-16 
dioxo-5',6'-dihydrospiro[indoline-3,4'-pyrano[3,2-c]quino-line)-3'-17 
carbonitrile.2DMF. Displacement parameters are drawn at 50% probability 18 
level. 19 
Figure 4. Molecular structure of 3c. 2DMF. 2'-amino-9'-bromo-2,5'-dioxo-20 
5',6'-dihydrospiro(indoline-3,4'-pyrano[3,2-c]quino-line)-3'-21 
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carbonitrile.2DMF (1:2). Displacement parameters are drawn at 50% 1 
probability level. 2 
Figure 5. Molecular structure of 3f. DMF2'-Amino-6'-ethyl-2,5'-dioxo-3 
5',6'-dihydrospiro(indoline-3,4'-pyrano[3,2-c]quinoline)-3'-4 
carbonitrile.DMF (1:1). Displacement parameters are drawn at 50% 5 
probability level. 6 
Scheme 2. Suggested mechanism for formation of products 3a-f 7 
 8 
Table Captions 9 
Table 1. NMR assignment of compound 3e 1H NMR 10 
Table 2. NMR assignment of compound 3a 1H NMR 11 
 12 
